Sign in

NCT07388147Not yet recruiting

Exercise Therapy for Multiple Myeloma Patients

Structural Measures for Multiple Myeloma Patients to Improve Rehabilitation by Exercise Therapy

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

Physical exercise is an important supportive therapy for cancer patients, as it improves quality of life in general and might mitigate the side effects of drug treatment. For patients with multiple myeloma in particular, significantly less evidence on the effectiveness of exercise therapy is available due to the fact that this disease is associated with severe bone degradation which might affect bone stability. Advances in oncologic drug treatment have improved overall survival in multiple myeloma significantly. Therefore, there is an increased interest for recommendations on physical activity in this patient group. Due to uncertainties regarding safety and feasibility of exercise therapy in multiple myeloma, both patients and therapists often remain hesitant. Therefore, an orthopaedic outpatient clinic has been established at the Myeloma Center of Heidelberg University Hospital. Here, patients receive consultation on bone stability and individualized physical exercise plans. Based on the expertise gained at the orthopaedic outpatient clinic, the aim of this study is to establish and evaluate structural measures for improved rehabilitation in multiple myeloma and to integrate them into routine clinical care.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
71 (estimated)
First submitted
19 Jan 2026
Start date
1 Mar 2026
Primary completion date
31 Mar 2029
Lead sponsor
University Hospital Heidelberg
NCT number
NCT07388147

What you commit to

  • Study type: Interventional
  • Planned participants: 71
  • From 1 Mar 2026 to the primary completion date, 31 Mar 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • physical or mental limitation that would prevent participation in the training program or the planned follow-up visits

Who the study is looking for

  • newly diagnosed multiple myeloma
  • Survival prognosis \> 6 months
  • ECOG status ≤ 3
  • Age ≥18 years
  • Patients who state that they want to carry out the training program at least 2 x/week and participate in the planned follow-up visits
  • Ability to give informed consent
  • Written consent to participate in the study
  • Sufficient knowledge of written and spoken German

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Heidelberg University Hospital - GMMG Study Group
Coordinator of this site? Confirm its status
HeidelbergGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.